Biological markers for non-small cell lung cancer patient selection for epidermal growth factor receptor tyrosine kinase inhibitor therapy

被引：48
|
作者：
Bunn, Paul A., Jr.
Dziadziuszko, Rafal
Varella-Garcia, Marileila
Franklin, WilburA.
Witta, Samir E.
Kelly, Karen
Hirsch, Fred R.
机构：
[1] Univ Colorado, Ctr Canc, Dept Med, Aurora, CO 80045 USA
[2] Univ Colorado, Ctr Canc, Dept Pathol, Aurora, CO 80045 USA
[3] Univ Colorado, Hlth Sci Ctr, Aurora, CO USA
[4] Med Univ Gdansk, Dept Oncol & Radiotherapy, Gdansk, Poland
来源：
CLINICAL CANCER RESEARCH | 2006年 / 12卷 / 12期
关键词：
D O I：
10.1158/1078-0432.CCR-06-0261
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
[No abstract available]
引用
收藏
页码：3652 / 3656
页数：5
相关论文
共 50 条
  • [1] Surgery for advanced non-small cell lung cancer patient after epidermal growth factor receptor tyrosine kinase inhibitor neoadjuvant therapy
    Ning, Ye
    Bao, Minwei
    Yan, Xiaoxia
    Xie, Dong
    Jiang, Gening
    ANNALS OF TRANSLATIONAL MEDICINE, 2018, 6 (20)
  • [2] ACTIVATION OF CYTOMEGALOVIRUS IN A PATIENT ON EPIDERMAL GROWTH FACTOR RECEPTOR TYROSINE KINASE INHIBITOR TREATMENT IN NON-SMALL CELL LUNG CANCER
    Dawes, Sean M.
    Plichta, Christine
    Gaddipati, Himaja
    Hamade, Sam
    Biedny, Adam
    de Villate, Oscar F. Parodi Ortiz
    CHEST, 2023, 164 (04) : 972A - 973A
  • [3] Addressing epidermal growth factor receptor tyrosine kinase inhibitor resistance in non-small cell lung cancer
    Noda, Shoko
    Kanda, Shintaro
    EXPERT REVIEW OF RESPIRATORY MEDICINE, 2016, 10 (05) : 547 - 556
  • [4] Combined therapy with epidermal growth factor receptor tyrosine kinase inhibitors for non-small cell lung cancer
    Iwama, Eiji
    Nakanishi, Yoichi
    Okamoto, Isamu
    EXPERT REVIEW OF ANTICANCER THERAPY, 2018, 18 (03) : 267 - 276
  • [5] Epidermal growth factor receptor tyrosine kinase inhibitors for non-small cell lung cancer
    Asami, Kazuhiro
    Atagi, Shinji
    WORLD JOURNAL OF CLINICAL ONCOLOGY, 2014, 5 (04): : 646 - 659
  • [6] PET probe detecting non-small cell lung cancer susceptible to epidermal growth factor receptor tyrosine kinase inhibitor therapy
    Makino, Akira
    Miyazaki, Anna
    Tomoike, Ayaka
    Kimura, Hiroyuki
    Arimitsu, Kenji
    Hirata, Masahiko
    Ohmomo, Yoshiro
    Nishii, Ryuichi
    Okazawa, Hidehiko
    Kiyono, Yasushi
    Ono, Masahiro
    Saji, Hideo
    BIOORGANIC & MEDICINAL CHEMISTRY, 2018, 26 (08) : 1609 - 1613
  • [7] Thoracic Surgery in Non-Small Cell Lung Cancer with Epidermal Growth Factor Receptor Mutant After Tyrosine Kinase Inhibitor Therapy
    Hsiao, C.
    Kuo, S.
    Chen, K.
    Chen, J.
    JOURNAL OF THORACIC ONCOLOGY, 2018, 13 (10) : S474 - S474
  • [8] THE ROLE EPIDERMAL GROWTH FACTOR RECEPTOR TYROSINE KINASE INHIBITOR IN MANAGEMENT OF ADVANCED NON-SMALL CELL LUNG CANCER
    Mok, Tony
    ANNALS OF ONCOLOGY, 2010, 21 : 5 - 5
  • [9] Fluorescence Imaging of Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitor Resistance in Non-Small Cell Lung Cancer
    Martin-Fernandez, Marisa L.
    CANCERS, 2022, 14 (03)
  • [10] Epidermal growth factor receptor tyrosine kinase inhibitors for the treatment of non-small cell lung cancer
    Kujtan, Lara
    Subramanian, Janakiraman
    EXPERT REVIEW OF ANTICANCER THERAPY, 2019, 19 (07) : 547 - 559
12345